AZD-5672

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameAZD-5672
Drug Alias NameAZD5672AZD-5672
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionC-C chemokine receptor type 5 modulators
TargetsC-C chemokine receptor type 5
Therapy Area/IndicationsRenal InsufficiencyArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBulgariaUkraine +[16] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstrazeneca Plc
Active IndicationsN/A
Inactive IndicationsRenal InsufficiencyArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A